Enzymatica continues to scale up its commitment to the UK market. Shortly after announcing its partnership with GB Snowsport, the company is now taking the next step through a collaboration with the UK Sports Institute (UKSI), a central organisation within British high-performance sport. BioStock reached out to Enzymatica’s CEO, Claus Egstrand, to learn more about what the partnership means for the company.

Read the full article at biostock.se:
https://biostock.se/en/2025/11/enzymatica-inleder-samarbete-med-uk-sports-institute-for-att-starka-elitidrottares-halsa/
This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!  

About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Läs mer på BioStock

Ämnen i artikeln

Enzymatica

Senast

1,84

1 dag %

−2,90%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån